What changed 10-K

Item 2. Properties

2024-02-29 compared with 2023-03-02 · 8 added, 9 removed, 0 unchanged (100% of the section changed)

and Facilities

lease a 14,507 square foot manufacturing facility in Irvine, California.

Our lease expires on September 30, 2027, providing a remaining

term of approximately fifty-four (54) months from the date of filing this Form 10-K.

Our facility is designed expressly for the manufacture

of biologic vascular grafts and is equipped for research and development, prototype fabrication, cGMP manufacturing and shipping for

Class III medical devices, including biologic cardiovascular devices.

We believe that our facilities are sufficient for the near future

as there is present capacity to manufacture up to approximately 24,000 venous valves per year to meet potential market demands.

Properties and Facilities

lease a 14,507 square foot manufacturing facility in Irvine, California under a lease that expires on September 30, 2027.

Our facility is designed expressly

for the manufacture of biologic vascular grafts and is equipped for research and development, prototype fabrication, cGMP

manufacturing and shipping for Class III medical devices, including biologic cardiovascular devices.

We believe that our facilities

are sufficient for the near future as there is present capacity to manufacture up to approximately 24,000 venous valves per year to

meet potential market demands.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.